# I-125 Versus Pd-103 for Low Risk Prostate Cancer

> **NCT00494039** · PHASE3 · UNKNOWN · sponsor: **VA Puget Sound Health Care System** · enrollment: 602 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Radioactive seed implant to prostate

## Key facts

- **NCT ID:** NCT00494039
- **Lead sponsor:** VA Puget Sound Health Care System
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-01
- **Primary completion:** —
- **Final completion:** 2010-01
- **Target enrollment:** 602 (ACTUAL)
- **Last updated:** 2007-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00494039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00494039, "I-125 Versus Pd-103 for Low Risk Prostate Cancer". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00494039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*